Control of innate immunity by rapamycin ( mTOR)

proteomics dataset

We obtained data on the control of innate immunity by the mammalian target of Rapamycin (m-TOR) by enhancing TLR driven production of proinflammatory cytokines and type 1 interferons and by repressing posttranslational processing, via the inflammasome, of IL-1beta.

We will further analyse the impact of the m-TOR inhibitor Rapamycin on innate immunity.